These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 9864230)

  • 1. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
    Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
    Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.
    Castagliuolo I; LaMont JT; Nikulasson ST; Pothoulakis C
    Infect Immun; 1996 Dec; 64(12):5225-32. PubMed ID: 8945570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.
    Pothoulakis C; Kelly CP; Joshi MA; Gao N; O'Keane CJ; Castagliuolo I; Lamont JT
    Gastroenterology; 1993 Apr; 104(4):1108-15. PubMed ID: 8462799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis.
    Chen X; Kokkotou EG; Mustafa N; Bhaskar KR; Sougioultzis S; O'Brien M; Pothoulakis C; Kelly CP
    J Biol Chem; 2006 Aug; 281(34):24449-54. PubMed ID: 16816386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins.
    Kelly CP; Pothoulakis C; Vavva F; Castagliuolo I; Bostwick EF; O'Keane JC; Keates S; LaMont JT
    Antimicrob Agents Chemother; 1996 Feb; 40(2):373-9. PubMed ID: 8834883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antisera from Clostridium difficile-infected mice on toxin-A-induced colonic epithelial cell death signaling.
    Kim DH; Lee IH; Nam ST; Nam HJ; Kang JK; Seok H; Hwang JS; Kim H
    J Microbiol Biotechnol; 2014 May; 24(5):696-703. PubMed ID: 24509250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits.
    Ketley JM; Mitchell TJ; Candy DC; Burdon DW; Stephen J
    J Med Microbiol; 1987 Aug; 24(1):41-52. PubMed ID: 3612743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.
    Castex F; Corthier G; Jouvert S; Elmer GW; Lucas F; Bastide M
    J Gen Microbiol; 1990 Jun; 136(6):1085-9. PubMed ID: 2200843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Response of the IRD intestinal epithelial cell line to Clostridium difficile toxins A and B in rats. Effect of Saccharomyces boulardii].
    Czerucka D; Nano JL; Bernasconi P; Rampal P
    Gastroenterol Clin Biol; 1991; 15(1):22-7. PubMed ID: 1849105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
    Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
    J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.
    Qamar A; Aboudola S; Warny M; Michetti P; Pothoulakis C; LaMont JT; Kelly CP
    Infect Immun; 2001 Apr; 69(4):2762-5. PubMed ID: 11254650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat.
    Izadnia F; Wong CT; Kocoshis SA
    Dig Dis Sci; 1998 Sep; 43(9):2055-60. PubMed ID: 9753273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.
    Kelly CP; Pothoulakis C; Orellana J; LaMont JT
    Gastroenterology; 1992 Jan; 102(1):35-40. PubMed ID: 1309359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus amyloliquefaciens as prophylactic treatment for Clostridium difficile-associated disease in a mouse model.
    Geeraerts S; Ducatelle R; Haesebrouck F; Van Immerseel F
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1275-80. PubMed ID: 25800047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The American Cockroach Peptide Periplanetasin-2 Blocks
    Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
    J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet model.
    Cohen OR; Steele JA; Zhang Q; Schmidt DJ; Wang Y; Hamel PE; Beamer G; Xu B; Tzipori S
    PLoS One; 2014; 9(10):e111075. PubMed ID: 25347821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.
    Ishida Y; Maegawa T; Kondo T; Kimura A; Iwakura Y; Nakamura S; Mukaida N
    J Immunol; 2004 Mar; 172(5):3018-25. PubMed ID: 14978106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
    Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon.
    Pothoulakis C; Galili U; Castagliuolo I; Kelly CP; Nikulasson S; Dudeja PK; Brasitus TA; LaMont JT
    Gastroenterology; 1996 Jun; 110(6):1704-12. PubMed ID: 8964394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury.
    Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF
    J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.